Callan Capital, LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Callan Capital, LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$97,482
-16.6%
103,4620.0%0.01%
-23.1%
Q2 2023$116,912
-11.0%
103,4620.0%0.01%
-13.3%
Q1 2023$131,397
+67.9%
103,4620.0%0.02%
+50.0%
Q4 2022$78,248
-35.9%
103,462
+773.1%
0.01%
-80.0%
Q2 2016$122,00011,8500.05%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,356,813$3,189,0004.48%
Omega Fund Management, LLC 1,508,794$3,546,0002.63%
ALETHEA CAPITAL MANAGEMENT, LLC 482,357$1,134,0001.65%
Opaleye Management Inc. 1,200,000$2,820,0001.05%
BVF INC/IL 2,904,684$6,826,0000.89%
FRAZIER MANAGEMENT LLC 1,312,258$3,084,0000.80%
Monashee Investment Management LLC 480,851$1,130,0000.76%
Aisling Capital LLC 1,021,148$2,400,0000.68%
Trellus Management Company, LLC 94,143$221,0000.50%
Prosight Management, LP 245,764$578,0000.30%
View complete list of CIDARA THERAPEUTICS INC shareholders